Dr Reddy’s Labs net profit doubles in Q1: What should investors do?
Dr Reddy’s Laboratories failed to cheer Dalal Street despite reporting over a 100 per cent rise in the net profit for the quarter ended June 2022. Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well … Read more
